Literature DB >> 10521261

Isomerization of all-trans-9- and 13-desmethylretinol by retinal pigment epithelial cells.

H Stecher1, O Prezhdo, J Das, R K Crouch, K Palczewski.   

Abstract

Photoisomerization of 11-cis-retinal to all-trans-retinal triggers phototransduction in the retinal photoreceptor cells and causes ultimately the sensation of vision. 11-cis-Retinal is enzymatically regenerated through a complex set of reactions in adjacent retinal pigment epithelial cells (RPE). In this study using all-trans-9-desmethylretinol (lacking the C(19) methyl group) and all-trans-13-desmethylretinol (lacking the C(20) methyl group), we explored the effects of C(19) and C(20) methyl group removals on isomerization of these retinols in RPE microsomes. The C(19) methyl group may be involved in the substrate activation, whereas the C(20) methyl group causes steric hindrance with a proton in position C(10) of 11-cis-retinol; thus, removal of this group could accelerate isomerization. We found that all-trans-9-desmethylretinol and all-trans-13-desmethylretinol are isomerized to their corresponding 11-cis-alcohols, although with lower efficiencies than isomerization of all-trans-retinol to 11-cis-retinol. These findings make the mechanism of isomerization through the C(19) methyl group unlikely, because in the case of 9-desmethylretinol, the isomerization would have to progress by proton abstraction from electron-rich olefinic C(9). The differences between all-trans-retinol, all-trans-9-desmethylretinol, and all-trans-13-desmethylretinol appear to be a consequence of the enzymatic properties, and binding affinities of the isomerization system, rather than differences in the chemical or thermodynamic properties of these compounds. This observation is also supported by quantum chemical calculations. It appears that both methyl groups are not essential for the isomerization reaction and are not likely involved in formation of a transition stage during the isomerization process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10521261     DOI: 10.1021/bi9913294

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  How a small change in retinal leads to G-protein activation: initial events suggested by molecular dynamics calculations.

Authors:  Paul S Crozier; Mark J Stevens; Thomas B Woolf
Journal:  Proteins       Date:  2007-02-15

Review 2.  The biochemical and structural basis for trans-to-cis isomerization of retinoids in the chemistry of vision.

Authors:  Johannes von Lintig; Philip D Kiser; Marcin Golczak; Krzysztof Palczewski
Journal:  Trends Biochem Sci       Date:  2010-02-24       Impact factor: 13.807

3.  Characterization of a dehydrogenase activity responsible for oxidation of 11-cis-retinol in the retinal pigment epithelium of mice with a disrupted RDH5 gene. A model for the human hereditary disease fundus albipunctatus.

Authors:  G F Jang; J P Van Hooser; V Kuksa; J K McBee; Y G He; J J Janssen; C A Driessen; K Palczewski
Journal:  J Biol Chem       Date:  2001-06-20       Impact factor: 5.157

4.  Isomerization of all-trans-retinol to cis-retinols in bovine retinal pigment epithelial cells: dependence on the specificity of retinoid-binding proteins.

Authors:  J K McBee; V Kuksa; R Alvarez; A R de Lera; O Prezhdo; F Haeseleer; I Sokal; K Palczewski
Journal:  Biochemistry       Date:  2000-09-19       Impact factor: 3.162

Review 5.  Membrane-binding and enzymatic properties of RPE65.

Authors:  Philip D Kiser; Krzysztof Palczewski
Journal:  Prog Retin Eye Res       Date:  2010-03-19       Impact factor: 21.198

6.  Isomerization of 11-cis-retinoids to all-trans-retinoids in vitro and in vivo.

Authors:  J K McBee; J P Van Hooser; G F Jang; K Palczewski
Journal:  J Biol Chem       Date:  2001-10-16       Impact factor: 5.157

7.  Effects of prolonged dark adaptation in patients with retinitis pigmentosa of Bothnia type: an electrophysiological study.

Authors:  Marie S I Burstedt; Ola Sandgren; Irina Golovleva; Lillemor Wachtmeister
Journal:  Doc Ophthalmol       Date:  2007-10-06       Impact factor: 2.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.